Comparison 3. IDA versus DOX.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 CR‐overall analysis	2	187	Risk Ratio (M‐H, Fixed, 95% CI)	1.28 [1.03, 1.59]
2 CR‐sensitivity analysis by random‐effects analysis	2	187	Risk Ratio (M‐H, Random, 95% CI)	1.29 [1.04, 1.60]
3 CR‐subgroup analysis by dose of IDA	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
3.1 12 mg/m²/d	1	87	Risk Ratio (M‐H, Fixed, 95% CI)	1.43 [1.06, 1.95]
3.2 20 mg/m²/d	1	100	Risk Ratio (M‐H, Fixed, 95% CI)	1.15 [0.85, 1.57]
4 CR‐subgroup by AML subtype	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
4.1 APL	1	12	Risk Ratio (M‐H, Fixed, 95% CI)	1.0 [0.50, 2.00]
4.2 non‐APL AML	1	88	Risk Ratio (M‐H, Fixed, 95% CI)	1.16 [0.83, 1.62]